These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
662 related articles for article (PubMed ID: 17426250)
1. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250 [TBL] [Abstract][Full Text] [Related]
2. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732 [TBL] [Abstract][Full Text] [Related]
3. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 protein is common in premalignant head and neck lesions. Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533 [TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210 [TBL] [Abstract][Full Text] [Related]
6. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Yarbrough WG Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329 [TBL] [Abstract][Full Text] [Related]
7. Mouse models for human head and neck squamous cell carcinomas. Lu SL; Herrington H; Wang XJ Head Neck; 2006 Oct; 28(10):945-54. PubMed ID: 16721744 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Edström S; Cvetkovska E; Westin T; Young C Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880 [TBL] [Abstract][Full Text] [Related]
9. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of the p53 gene in primary and metastatic head and neck carcinomas. Sauter ER; Ridge JA; Trock B; Cleveland D; Whitley KV; Mohr RM; Klein-Szanto A Laryngoscope; 1995 Jun; 105(6):653-6. PubMed ID: 7769953 [TBL] [Abstract][Full Text] [Related]
11. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas. Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897 [TBL] [Abstract][Full Text] [Related]
13. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck]. Schipper JH; Kelker W HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915 [TBL] [Abstract][Full Text] [Related]
14. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Tokumaru Y; Yamashita K; Osada M; Nomoto S; Sun DI; Xiao Y; Hoque MO; Westra WH; Califano JA; Sidransky D Cancer Res; 2004 Sep; 64(17):5982-7. PubMed ID: 15342377 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882 [TBL] [Abstract][Full Text] [Related]
16. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein. Leng K; Schlien S; Bosch FX J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249 [TBL] [Abstract][Full Text] [Related]
17. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915 [TBL] [Abstract][Full Text] [Related]
18. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Crowe DL; Sinha UK Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195 [TBL] [Abstract][Full Text] [Related]
19. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301 [TBL] [Abstract][Full Text] [Related]
20. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]